Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators
Abstract Background Steps have been taken by pharmaceutical companies to obtain marketing authorisation of PSMA ligands in the European Union. Since December 2022, Locametz® (PSMA-11, gozetotide) is licensed as kit for manual radiolabelling with gallium-68 and commercially available since mid-2023....
Saved in:
Main Authors: | Elke A. van Brandwijk (Author), Else A. Aalbersberg (Author), Arman S. Hosseini (Author), Alwin D. R. Huitema (Author), Jeroen J. M. A. Hendrikx (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
by: Else A. Aalbersberg, et al.
Published: (2020) -
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
by: Melissa E. Rodnick, et al.
Published: (2020) -
Fully automated radiosynthesis of [68Ga]Ga-FAPI-46 with cyclotron produced gallium
by: Adam J. Rosenberg, et al.
Published: (2023) -
Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [<sup>68</sup>Ge]Ge/[<sup>68</sup>Ga]Ga Generators: Fractional Elution or Prepurification?
by: Flore Durieux, et al.
Published: (2023) -
[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021)